ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
Drug Farm secured $55 million in the first close of its Series D funding round. The financing will support the clinical development of the company's drug candidates. The round was led by new and existing investors.
Tap to vote and see what everyone thinks.
Summary by ByteBrief
FORE Biotherapeutics Raises $67.4M Series D-2